Performance of Commercially Available Serological Screening Tests for Human T-Cell Lymphotropic Virus Infection in Brazil-Reference-Cited by-同舟云学术

Performance of Commercially Available Serological Screening Tests for Human T-Cell Lymphotropic Virus Infection in Brazil

Published:2018-12 Issue:12 Volume:56 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

da Silva Brito Vanessa¹,Santos Fred Luciano Neves²^ORCID,Gonçalves Noilson Lazaro Sousa¹²,Araujo Thessika Hialla Almeida¹,Nascimento Davi Silva Vale¹,Pereira Felicidade Mota³,Boa-Sorte Ney Cristian Amaral¹,Grassi Maria Fernanda Rios¹²,Caterino-de-Araujo Adele⁴,Galvão-Castro Bernardo¹²

Affiliation:

1. Integrated and Multidisciplinary HTLV Center, Bahiana School of Medicine and Public Health (EBMSP), Salvador, Bahia, Brazil

2. Advanced Laboratory of Public Health, Gonçalo Moniz Institute (IGM), FIOCRUZ-BA, Salvador, Bahia, Brazil

3. Gonçalo Moniz Public Health Central Laboratory (LACEN-BA), Bahia State Department of Health, Bahia, Brazil

4. Adolfo Lutz Institute, São Paulo, São Paulo, Brazil

Abstract

Serological screening for human T-cell lymphotropic virus type 1 (HTLV-1) is usually performed using enzyme-linked immunosorbent assay (ELISA), particle agglutination, or chemiluminescence assay kits. Due to an antigen matrix improvement entailing the use of new HTLV antigens and changes in the format of HTLV screening tests, as well as newly introduced chemiluminescence assays (CLIAs), a systematic evaluation of the accuracy of currently available commercial tests is warranted.

Funder

MCTI | Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado da Bahia

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00961-18

Reference46 articles.

1. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

2. A New Subtype of Human T-Cell Leukemia Virus (HTLV-II) Associated with a T-Cell Variant of Hairy Cell Leukemia